VIVUS Inc. (VVUS)

4.32
NASDAQ : Health Technology
Prev Close 3.98
Day Low/High 3.77 / 4.32
52 Wk Low/High 2.15 / 6.41
Avg Volume 80.30K
Exchange NASDAQ
Shares Outstanding 10.64M
Market Cap 42.36M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Manhattan Continues To Seek Settlement Despite Bad Faith Negotiating Tactics From Vivus’ Existing Board

First Manhattan Continues To Seek Settlement Despite Bad Faith Negotiating Tactics From Vivus’ Existing Board

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

First Manhattan Asks Delaware Court To Certify Results Of Vivus’ Annual Meeting

First Manhattan Asks Delaware Court To Certify Results Of Vivus’ Annual Meeting

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

First Manhattan Objects To Adjournment Of Vivus Annual Meeting

First Manhattan Objects To Adjournment Of Vivus Annual Meeting

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

First Manhattan Calls Adjournment Of Annual Meeting By The Vivus Board A Desperate Act To Disenfranchise Shareholders

First Manhattan Calls Adjournment Of Annual Meeting By The Vivus Board A Desperate Act To Disenfranchise Shareholders

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

The Deal: Vivus Could Get a Bitter Dose at Shareholder Meeting

The Deal: Vivus Could Get a Bitter Dose at Shareholder Meeting

Come July 15, shareholders of Vivus should know who is in charge at the drugmaker, but the question is whether that leadership will include current management or a new slate of directors.

Playing Obesity Drugs the ETF Way

Playing Obesity Drugs the ETF Way

Liquidity is key, and one ETF stands above the rest.

VIVUS Reminds Stockholders To Vote The GOLD Proxy Card By Telephone Or Internet Today

VIVUS Reminds Stockholders To Vote The GOLD Proxy Card By Telephone Or Internet Today

VIVUS's Board and Management Team Successfully Executing on the Right Strategy to Maximize Stockholder Value

Fix Vivus Now – Elect Nine New Independent Directors

Fix Vivus Now – Elect Nine New Independent Directors

First Manhattan Co., the owner of approximately 9.

Obesity Treatment Shift Could Aid Stocks

Obesity Treatment Shift Could Aid Stocks

Obesity costs are a  pain point, which  often create good investments.

VIVUS Board And Management Team Successfully Executing Plan To Unlock The Full Potential Of Qsymia

VIVUS Board And Management Team Successfully Executing Plan To Unlock The Full Potential Of Qsymia

Stockholders Urged to Vote FOR the Board's Nominees on the GOLD Proxy Card Today

(Graphic: Business Wire)

(Graphic: Business Wire)

Please replace the release with the following corrected version due to certain revisions.

The Best-Performing Obesity Drug Stock May Surprise You

The Best-Performing Obesity Drug Stock May Surprise You

Hint: It's not Vivus or Arena Pharmaceuticals...

ISS And Egan Jones Recommend That Vivus Stockholders Vote For First Manhattan’s Nominees For Election To Vivus Board

ISS And Egan Jones Recommend That Vivus Stockholders Vote For First Manhattan’s Nominees For Election To Vivus Board

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

(Graphic: Business Wire)

(Graphic: Business Wire)

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the beneficial holder of approximately 9.

First Manhattan Announces That Anthony Zook Has Agreed To Serve As Vivus CEO If Its Director Nominees Are Elected

First Manhattan Announces That Anthony Zook Has Agreed To Serve As Vivus CEO If Its Director Nominees Are Elected

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

VIVUS Mails Letter To Stockholders

VIVUS Mails Letter To Stockholders

The VIVUS Board of Directors Urges Stockholders to Vote FOR the Board's Nominees on the GOLD Proxy Card Today

Arena Fans Spinning (And Altering) Belviq Prescription Data

Arena Fans Spinning (And Altering) Belviq Prescription Data

Not much can be said from two weeks of Belviq scripts, but that isn't stopping Areniacs from trying.

VIVUS Announces Initial Availability Of Qsymia(R) Through Certified Retail Pharmacies

VIVUS Announces Initial Availability Of Qsymia(R) Through Certified Retail Pharmacies

New Discount Programs Further Reduce Out-of-Pocket Costs for Patients

(Graphic: Business Wire)

(Graphic: Business Wire)

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

VIVUS Clarifies Additional Misstatements By First Manhattan Co.

VIVUS Clarifies Additional Misstatements By First Manhattan Co.

Stockholders Urged to Vote FOR the Board's Nominees on GOLD Proxy Card Today

Vivus (VVUS): Today's Featured Health Care Laggard

Vivus (VVUS): Today's Featured Health Care Laggard

Vivus was a leading decliner within the health care sector, falling $0.39 (-3.0%) to $12.48 on average volume

FMC = RISK: Vote The GOLD Proxy Card

FMC = RISK: Vote The GOLD Proxy Card

First Manhattan Outlines Strategic Plan To Fix VIVUS

First Manhattan Outlines Strategic Plan To Fix VIVUS

First Manhattan Co. (“FMC”), an owner-managed and operated investment advisory firm and the owner of approximately 9.

TheStreet Quant Rating: D (Sell)